These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22345691)

  • 1. Exploring clinical predictors of cardiovascular disease in a central Australian Aboriginal cohort.
    Luke JN; Brown AD; Brazionis L; O'Dea K; Best JD; McDermott RA; Wang Z; Wang Z; Rowley KG
    Eur J Prev Cardiol; 2013 Apr; 20(2):246-53. PubMed ID: 22345691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes associated with albuminuria in central Australia: a cohort study.
    Ritte R; Luke J; Nelson C; Brown A; O'Dea K; Jenkins A; Best JD; McDermott R; Daniel M; Rowley K
    BMC Nephrol; 2016 Aug; 17(1):113. PubMed ID: 27495237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease.
    Redfern J; Tu Q; Hyun K; Hollings MA; Hafiz N; Zwack C; Free C; Perel P; Chow CK
    Cochrane Database Syst Rev; 2024 Mar; 3(3):CD011851. PubMed ID: 38533994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stemming the tide: reducing cardiovascular disease and renal failure in Australian Aborigines.
    Hoy W; Kelly A; Jacups S; McKendry K; Baker P; MacDonald S; Wang Z; Punguatji N; Kerinauia J; Tipiloura E; Tipiloura E; Harrison C
    Aust N Z J Med; 1999 Jun; 29(3):480-3. PubMed ID: 10868523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment.
    Lim AWY; Schneider L; Loy C
    Cochrane Database Syst Rev; 2024 Nov; 11(11):CD001747. PubMed ID: 39498781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of CKD in Australian indigenous and nonindigenous children: a population-based cohort study.
    Haysom L; Williams R; Hodson E; Lopez-Vargas P; Roy LP; Lyle D; Craig JC
    Am J Kidney Dis; 2009 Feb; 53(2):229-37. PubMed ID: 18930569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Education programmes for people with chronic kidney disease and diabetes.
    Cashmore BA; Cooper TE; Evangelidis NM; Green SC; Lopez-Vargas P; Tunnicliffe DJ
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD007374. PubMed ID: 39171639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meditation for the primary and secondary prevention of cardiovascular disease.
    Rees K; Takeda A; Court R; Kudrna L; Hartley L; Ernst E
    Cochrane Database Syst Rev; 2024 Feb; 2(2):CD013358. PubMed ID: 38358047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of cardiometabolic risk factors to estimated glomerular filtration rate decline in Indigenous Australians with and without albuminuria - the eGFR Follow-up Study.
    Barr EL; Barzi F; Hughes JT; Jerums G; O'Dea K; Brown AD; Ekinci EI; Jones GR; Lawton PD; Sinha A; MacIsaac RJ; Cass A; Maple-Brown LJ
    Nephrology (Carlton); 2018 Jul; 23(7):682-689. PubMed ID: 28503768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostatic factors in Australian Aboriginal and Torres Strait Islander populations.
    Wang Z; Rowley K; Best J; McDermott R; Taylor M; O'Dea K
    Metabolism; 2007 May; 56(5):629-35. PubMed ID: 17445537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of an Aboriginal community-based renal disease management program incorporating point of care testing for urine albumin:creatinine ratio.
    Shephard MD; Allen GG; Paizis K; Barbara JA; Batterham M; Vanajek A
    Rural Remote Health; 2006; 6(4):591. PubMed ID: 17022724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes as a risk factor for tuberculosis disease.
    Franco JV; Bongaerts B; Metzendorf MI; Risso A; Guo Y; Peña Silva L; Boeckmann M; Schlesinger S; Damen JA; Richter B; Baddeley A; Bastard M; Carlqvist A; Garcia-Casal MN; Hemmingsen B; Mavhunga F; Manne-Goehler J; Viney K
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD016013. PubMed ID: 39177079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease risk assessment for Aboriginal and Torres Strait Islander adults aged under 35 years: a consensus statement.
    Agostino JW; Wong D; Paige E; Wade V; Connell C; Davey ME; Peiris DP; Fitzsimmons D; Burgess CP; Mahoney R; Lonsdale E; Fernando P; Malamoo L; Eades S; Brown A; Jennings G; Lovett RW; Banks E
    Med J Aust; 2020 May; 212(9):422-427. PubMed ID: 32172533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of White and African American groups reveals unique lipid and inflammatory features of diabetes.
    Pacheco Sanchez G; Lopez M; Velez LM; Tamburini I; Ujagar N; Ayala J; Robles G; Choi H; Arriola J; Kapadia R; Zonderman AB; Evans MK; Jang C; Seldin MM; Nicholas DA
    medRxiv; 2024 Nov; ():. PubMed ID: 39606357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein concentrations are very high and more stable over time than the traditional vascular risk factors total cholesterol and systolic blood pressure in an Australian aboriginal cohort.
    Shemesh T; Rowley KG; Jenkins AJ; Best JD; O'Dea K
    Clin Chem; 2009 Feb; 55(2):336-41. PubMed ID: 19074519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of prediction models for fetal growth restriction and birthweight: an individual participant data meta-analysis.
    Allotey J; Archer L; Coomar D; Snell KI; Smuk M; Oakey L; Haqnawaz S; Betrán AP; Chappell LC; Ganzevoort W; Gordijn S; Khalil A; Mol BW; Morris RK; Myers J; Papageorghiou AT; Thilaganathan B; Da Silva Costa F; Facchinetti F; Coomarasamy A; Ohkuchi A; Eskild A; Arenas Ramírez J; Galindo A; Herraiz I; Prefumo F; Saito S; Sletner L; Cecatti JG; Gabbay-Benziv R; Goffinet F; Baschat AA; Souza RT; Mone F; Farrar D; Heinonen S; Salvesen KÅ; Smits LJ; Bhattacharya S; Nagata C; Takeda S; van Gelder MM; Anggraini D; Yeo S; West J; Zamora J; Mistry H; Riley RD; Thangaratinam S
    Health Technol Assess; 2024 Aug; 28(47):1-119. PubMed ID: 39252507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.
    Sasongko TH; Nagalla S
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD009191. PubMed ID: 34932828
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.